176 related articles for article (PubMed ID: 12032292)
1. Complexation of peptidoglycan intermediates by the lipoglycodepsipeptide antibiotic ramoplanin: minimal structural requirements for intermolecular complexation and fibril formation.
Cudic P; Kranz JK; Behenna DC; Kruger RG; Tadesse H; Wand AJ; Veklich YI; Weisel JW; McCafferty DG
Proc Natl Acad Sci U S A; 2002 May; 99(11):7384-9. PubMed ID: 12032292
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of the lipoglycodepsipeptide antibiotic ramoplanin.
Cudic P; Behenna DC; Kranz JK; Kruger RG; Wand AJ; Veklich YI; Weisel JW; McCafferty DG
Chem Biol; 2002 Aug; 9(8):897-906. PubMed ID: 12204689
[TBL] [Abstract][Full Text] [Related]
3. Chemistry and biology of the ramoplanin family of peptide antibiotics.
McCafferty DG; Cudic P; Frankel BA; Barkallah S; Kruger RG; Li W
Biopolymers; 2002; 66(4):261-84. PubMed ID: 12491539
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the target sites and mechanisms of action of glycopeptide and lipoglycodepsipeptide antibiotics.
Reynolds PE; Somner EA
Drugs Exp Clin Res; 1990; 16(8):385-9. PubMed ID: 2151441
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of action of ramoplanin and enduracidin.
Fang X; Tiyanont K; Zhang Y; Wanner J; Boger D; Walker S
Mol Biosyst; 2006 Jan; 2(1):69-76. PubMed ID: 16880924
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of peptidoglycan biosynthesis by ramoplanin.
Somner EA; Reynolds PE
Antimicrob Agents Chemother; 1990 Mar; 34(3):413-9. PubMed ID: 2334153
[TBL] [Abstract][Full Text] [Related]
7. Molecular modeling of Gram-positive bacteria peptidoglycan layer, selected glycopeptide antibiotics and vancomycin derivatives modified with sugar moieties.
Ślusarz R; Szulc M; Madaj J
Carbohydr Res; 2014 May; 389():154-64. PubMed ID: 24685455
[TBL] [Abstract][Full Text] [Related]
8. Rethinking ramoplanin: the role of substrate binding in inhibition of peptidoglycan biosynthesis.
Helm JS; Chen L; Walker S
J Am Chem Soc; 2002 Nov; 124(47):13970-1. PubMed ID: 12440876
[TBL] [Abstract][Full Text] [Related]
9. Functional and biochemical analysis of a key series of ramoplanin analogues.
Fang X; Nam J; Shin D; Rew Y; Boger DL; Walker S
Bioorg Med Chem Lett; 2009 Nov; 19(21):6189-91. PubMed ID: 19783144
[TBL] [Abstract][Full Text] [Related]
10. Dissecting ramoplanin: mechanistic analysis of synthetic ramoplanin analogues as a guide to the design of improved antibiotics.
Chen L; Yuan Y; Helm JS; Hu Y; Rew Y; Shin D; Boger DL; Walker S
J Am Chem Soc; 2004 Jun; 126(24):7462-3. PubMed ID: 15198592
[TBL] [Abstract][Full Text] [Related]
11. The in vitro activity of ramoplanin (A-16686/MDL 62,198), vancomycin and teicoplanin against methicillin-susceptible and methicillin-resistant Staphylococcus spp.
O'Hare MD; Felmingham D; Grüneberg RN
Drugs Exp Clin Res; 1988; 14(10):617-9. PubMed ID: 2977587
[TBL] [Abstract][Full Text] [Related]
12. Imaging peptidoglycan biosynthesis in Bacillus subtilis with fluorescent antibiotics.
Tiyanont K; Doan T; Lazarus MB; Fang X; Rudner DZ; Walker S
Proc Natl Acad Sci U S A; 2006 Jul; 103(29):11033-8. PubMed ID: 16832063
[TBL] [Abstract][Full Text] [Related]
13. Ramoplanin inhibits bacterial transglycosylases by binding as a dimer to lipid II.
Hu Y; Helm JS; Chen L; Ye XY; Walker S
J Am Chem Soc; 2003 Jul; 125(29):8736-7. PubMed ID: 12862463
[TBL] [Abstract][Full Text] [Related]
14. Katanosin B and plusbacin A(3), inhibitors of peptidoglycan synthesis in methicillin-resistant Staphylococcus aureus.
Maki H; Miura K; Yamano Y
Antimicrob Agents Chemother; 2001 Jun; 45(6):1823-7. PubMed ID: 11353632
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Six Ramoplanin Family Gene Clusters and the Lipoglycodepsipeptide Chersinamycin*.
Morgan KT; Zheng J; McCafferty DG
Chembiochem; 2021 Jan; 22(1):176-185. PubMed ID: 32805078
[TBL] [Abstract][Full Text] [Related]
16. A crystal structure of a dimer of the antibiotic ramoplanin illustrates membrane positioning and a potential Lipid II docking interface.
Hamburger JB; Hoertz AJ; Lee A; Senturia RJ; McCafferty DG; Loll PJ
Proc Natl Acad Sci U S A; 2009 Aug; 106(33):13759-64. PubMed ID: 19666597
[TBL] [Abstract][Full Text] [Related]
17. Presence of UDP-N-acetylmuramyl-hexapeptides and -heptapeptides in enterococci and staphylococci after treatment with ramoplanin, tunicamycin, or vancomycin.
Billot-Klein D; Shlaes D; Bryant D; Bell D; Legrand R; Gutmann L; van Heijenoort J
J Bacteriol; 1997 Aug; 179(15):4684-8. PubMed ID: 9244253
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the substrate recognition of peptidoglycan pentapeptides by Enterococcus faecalis VanY
Kim HS; Hahn H; Kim J; Jang DM; Lee JY; Back JM; Im HN; Kim H; Han BW; Suh SW
Int J Biol Macromol; 2018 Nov; 119():335-344. PubMed ID: 30016658
[TBL] [Abstract][Full Text] [Related]
19. Structural variations of the cell wall precursor lipid II and their influence on binding and activity of the lipoglycopeptide antibiotic oritavancin.
Münch D; Engels I; Müller A; Reder-Christ K; Falkenstein-Paul H; Bierbaum G; Grein F; Bendas G; Sahl HG; Schneider T
Antimicrob Agents Chemother; 2015 Feb; 59(2):772-81. PubMed ID: 25403671
[TBL] [Abstract][Full Text] [Related]
20. New insights into glycopeptide antibiotic binding to cell wall precursors using SPR and NMR spectroscopy.
Treviño J; Bayón C; Ardá A; Marinelli F; Gandolfi R; Molinari F; Jimenez-Barbero J; Hernáiz MJ
Chemistry; 2014 Jun; 20(24):7363-72. PubMed ID: 24805824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
